Search research articles
Contact Us
Filters
Showing results (51-60 of 117) with videos related to
Page
of 12
Sort By:
Hematological Oncology
|
October 11, 2022
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study
Marzia Varettoni, Silvia Zibellini, Michele Merli, et al.
American Journal of Hematology
|
October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi
Giuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
Hematological Oncology
|
June 3, 2022
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib
Adalgisa Condoluci, Lisa Milan, Gabriela Forestieri, et al.
Journal of Geriatric Oncology
|
July 13, 2019
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi
Francesco Merli, Federica Cavallo, Flavia Salvi, et al.
Diagnostics (Basel, Switzerland)
|
April 30, 2021
MYD88<sup>L265P</sup> Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation
Martina Ferrante, Daniela Furlan, Silvia Zibellini, et al.
Leukemia
|
October 14, 2020
Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis
Barbara Mora, Claudia Siracusa, Elisa Rumi, et al.
Bone Marrow Transplantation
|
October 12, 2021
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation
Marco Salvini, Fabrizio Maggi, Camilla Damonte, et al.
Haematologica
|
November 26, 2013
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi
Michele Merli, Carlo Visco, Michele Spina, et al.
European Journal of Haematology
|
June 17, 2020
Primary pancreatic lymphoma: Clinical presentation, diagnosis, treatment, and outcome
Davide Facchinelli, Sokol Sina, Enrico Boninsegna, et al.
Haematologica
|
June 1, 2010
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma
Silvia Zibellini, Daniela Capello, Francesco Forconi, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 117) with videos related to
Sort By:
Page
of 12
Hematological Oncology
|
October 11, 2022
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study
Marzia Varettoni, Silvia Zibellini, Michele Merli, et al.
American Journal of Hematology
|
October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi
Giuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
Hematological Oncology
|
June 3, 2022
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib
Adalgisa Condoluci, Lisa Milan, Gabriela Forestieri, et al.
Journal of Geriatric Oncology
|
July 13, 2019
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi
Francesco Merli, Federica Cavallo, Flavia Salvi, et al.
Diagnostics (Basel, Switzerland)
|
April 30, 2021
MYD88<sup>L265P</sup> Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation
Martina Ferrante, Daniela Furlan, Silvia Zibellini, et al.
Leukemia
|
October 14, 2020
Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis
Barbara Mora, Claudia Siracusa, Elisa Rumi, et al.
Bone Marrow Transplantation
|
October 12, 2021
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation
Marco Salvini, Fabrizio Maggi, Camilla Damonte, et al.
Haematologica
|
November 26, 2013
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi
Michele Merli, Carlo Visco, Michele Spina, et al.
European Journal of Haematology
|
June 17, 2020
Primary pancreatic lymphoma: Clinical presentation, diagnosis, treatment, and outcome
Davide Facchinelli, Sokol Sina, Enrico Boninsegna, et al.
Haematologica
|
June 1, 2010
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma
Silvia Zibellini, Daniela Capello, Francesco Forconi, et al.
Page
of 12